← Mechanisms of action
VEGFA
SINGLE PROTEINHomo sapiens
Preferred name: Vascular endothelial growth factor A ChEMBL ↗
Linked proteins
Drugs acting on this target (92)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| 2-deoxy-d-ribose | Activator | experimental | Small molecule | VEGFA activator |
| 9mw0813 | Antagonist | experimental | Recombinant protein | VEGFA antagonist |
| askg712 | Antagonist | experimental | Recombinant protein | VEGF |
| b1962 | Antagonist | experimental | mAb | VEGF |
| bd0801 | Antagonist | experimental | mAb | VEGF |
| ctx-009 | Antagonist | experimental | mAb | VEGFA |
| faricimab (Vabysmo) | Antagonist | approved | mAb | VEGFA antagonist |
| ibi324 | Antagonist | experimental | mAb | VEGF |
| ibi333 | Antagonist | experimental | Small molecule | VEGF |
| omp-305b83 | Antagonist | experimental | mAb | VEGF |
| pegaptanib (macugen) | Antagonist | approved | Nucleic acid | VEGFA antagonist |
| pm8002 | Antagonist | experimental | mAb | VEGFA antagonist |
| agn 211745 | Antisense inhibitor | experimental | Nucleic acid | VEGFA antisense inhibitor |
| bevasiranib | Antisense inhibitor | experimental | Small molecule | VEGFA antisense inhibitor |
| hg202 | Antisense inhibitor | experimental | Gene therapy | VEGFA antisense inhibitor |
| vegf-antisense oligonucleotide | Antisense inhibitor | experimental | Nucleic acid | VEGFA antisense inhibitor |
| yl242 | Binding agent | experimental | mAb | VEGFA binding agent |
| vegf-a165 plasmid | Immunity, active | experimental | Vaccine | VEGFA immunity, active |
| abl-001 | Immunity, passive | experimental | mAb | VEGFA immunity, passive |
| abt-165 | Immunity, passive | experimental | mAb | VEGFA immunity, passive |
| acm-1 | Immunity, passive | experimental | mAb | VEGFA immunity, passive |
| kh631 | Immunity, passive | experimental | Gene therapy | VEGFA immunity, passive |
| 4d-150 | Inhibitor | experimental | Nucleic acid | VEGFA inhibitor |
| 601 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| abi-110 | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| abicipar pegol | Inhibitor | experimental | Recombinant protein | Vascular endothelial growth factor A inhibitor |
| aflibercept (zaltrap) | Inhibitor | approved | Recombinant protein | VEGFA inhibitor |
| ag-73305 | Inhibitor | experimental | Recombinant protein | inhibitor - vegf |
| ai-081 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| ak112 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| angiocal | Inhibitor | experimental | Small molecule | VEGFA inhibitor |
| antiprimod | Inhibitor | experimental | Small molecule | VEGFA inhibitor |
| ap505 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| axn-2510 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| bat5906 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| bevacizumab (avastin) | Inhibitor | approved | mAb | VEGFA inhibitor |
| bevacizumab in111 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| bevacizumab-irdye800cw | Inhibitor | experimental | mAb | VEGFA inhibitor |
| bi 836880 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| bnt327 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| brolucizumab-dbll (Beovu) | Inhibitor | approved | mAb | VEGFA inhibitor |
| conbercept (Lumitin) | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| cr-001 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| cs2009 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| ctx-10726 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| cvl006 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| cvx-241 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| endostatin (endostar) | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| es104 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| faricimab (Vabysmo) | Inhibitor | approved | mAb | Vascular endothelial growth factor A inhibitor |
| fs-8002 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| gb10 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| gb268 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| glycolic acid tetrasubstituted piceatannol | Inhibitor | experimental | Small molecule | VEGFA inhibitor |
| hlx37 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| hpv19 mab | Inhibitor | experimental | mAb | VEGFA inhibitor |
| hx9428 | Inhibitor | experimental | Small molecule | VEGFA inhibitor |
| ibi302 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| ibi3033 | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| imm2510 | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| Ixoberogene soroparvovec | Inhibitor | experimental | Gene therapy | VEGFA inhibitor |
| jl14002 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| js207 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| ks101 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| ksi-101 | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| ksi-301 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| lm-299 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| lyn00101 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| mg-o-1002 | Inhibitor | experimental | Small molecule | VEGFA inhibitor |
| mhb039a | Inhibitor | experimental | mAb | VEGFA inhibitor |
| nov1501 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| omp-305b83 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| opt-302 | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| pegaptanib (macugen) | Inhibitor | approved | Nucleic acid | Vascular endothelial growth factor A inhibitor |
| pi-88 | Inhibitor | experimental | Small molecule | VEGFA inhibitor |
| ranibizumab (lucentis) | Inhibitor | approved | mAb | VEGFA inhibitor |
| rc28-e | Inhibitor | experimental | mAb | VEGFA inhibitor |
| ro7250284 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| sct520ff | Inhibitor | experimental | mAb | VEGFA inhibitor |
| sctb14 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| sevacizumab | Inhibitor | experimental | mAb | VEGFA inhibitor |
| tab014 | Inhibitor | experimental | mAb | VEGFA inhibitor |
| telbermin | Inhibitor | experimental | Recombinant protein | VEGFA inhibitor |
| vanucizumab | Inhibitor | experimental | mAb | VEGFA inhibitor |
| azd8601 | Supplementation | experimental | Nucleic acid | VEGFA supplementation |
| bd311 | Supplementation | experimental | Gene therapy | VEGFA supplementation |
| ew-a-401 dna plasmid vector | Supplementation | experimental | Gene therapy | VEGFA supplementation |
| pcmv-vegf165 | Supplementation | experimental | Gene therapy | VEGFA supplementation |
| rhNEGF | Supplementation | experimental | Recombinant protein | VEGFA supplementation |
| vascular endothelial growth factor | Supplementation | experimental | Recombinant protein | VEGFA supplementation |
| vegf-a165/bfgf | Supplementation | experimental | Gene therapy | VEGFA supplementation |
| xc001 | Supplementation | experimental | Gene therapy | VEGFA supplementation |